InvestorsHub Logo
icon url

Blue Man

03/11/21 9:04 AM

#152360 RE: Longtimelong #152357

I think that is why they do the 50 trial to understand who it may help and then do the Phase 3. Lot's of irons in the fire around Cytodyn.
icon url

daemon57

03/11/21 9:11 AM

#152361 RE: Longtimelong #152357

longtimelong - LL is the only MAB that can cross the BBB, ie. 'brain fog' is top 3 most reported for PASC.
Basically, if LL is literally the ONLY 1 drug that can regulate and modulate the bodies own immune system and also cross the BBB AND can be done in the safety of one's own home AND is safe and effective as noted in subsects of the CD10/12.

You don't think that's worth 'trailing' for 50 patients? IMHO (no pump), this will probably be the game changer above CD16. This is just a bit further down this year for end results of this trial.

*edit - one very important thing to note. If CYDY gets' this right and we are first to market (for a 30B PASC treatment industry), this will be VERY BIG. I really really wouldn't be surprised we get offers (no pump) from BP, or at the very least partnership deals.

GLTU/A.